Trials / Completed
CompletedNCT00398476
Fluticasone Nasal Spray Patient Preference Study
A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Fluticasone Propionate Aqueous Nasal Spray in Subject With Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 127 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to evaluate and compare patient preference for FF (Fluticasone Furoate) and FP (Fluticasone Propionate Aqueous)nasal sprays in the treatment of allergic rhinitis following single-dose administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluticasone propionate (FP) | 200 micrograms (mcg); an aqueous suspension of microfine FP |
| DRUG | fluticasone furoate (FF) | 110 mcg; an aqueous suspension containing 0.05% w/w of micronized FF |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2006-12-04
- Completion
- 2006-12-04
- First posted
- 2006-11-10
- Last updated
- 2018-03-01
- Results posted
- 2018-01-29
Locations
14 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00398476. Inclusion in this directory is not an endorsement.